The University of Iowa

Iowa City, Iowa 52246

4 studies enrolling now · 39 studies all time

What they study most

AML, Abdominal Abscess, Adult ALL, Advanced Solid Tumor, Age Related Macular Degeneration, Anaplastic Astrocytoma, Aortic Stenosis, Asthma, Attention Deficit Disorder With Hyperactivity (ADHD), Breast Cancer, C3 Glomerulonephritis, C3 Glomerulopathy

Studies at this site

• A Study of Mezagitamab in Adults With Chronic Primary Immune Thrombocytopenia — Recruiting now
• A Follow-up Study of Mezagitamab in Adults With Chronic Primary Immune Thrombocytopenia — Recruiting now
• Investigating Mediodorsal Thalamus Representations Underlying Human Cognitive Flexibility — Recruiting now
• Middle Meningeal Artery Embolization (MMAE) Outcomes for Chronic Subdural Hematoma (cSDH) — Recruiting now
• Antibiotic Irrigations for Intra-Abdominal Drains — Recruiting now
• ABTECT - Maintenance — Running, not enrolling
• Cognitive Control Functions of the Human Thalamus — Completed
• Iterative Design of Custom Dynamic Orthoses — Completed
• Phase III Study Assessing the Efficacy and Safety of Pegcetacoplan in Patients With C3 Glomerulopathy or Immune-Complex Membranoproliferative Glomerulonephritis — Completed
• COMPASSION XT PAS - Post-approval Study of the SAPIEN XT THV in Patients With Pulmonary Valve Dysfunction — Completed
• ABTECT-2 - ABX464 Treatment Evaluation for Ulcerative Colitis Therapy -2 — Completed
• Symptom Screening Linked to Care Pathways — Completed
• A First-in-human Clinical Trial to Evaluate an Alpha-radiation Imaging Agent — Running, not enrolling
• A Clinical Trial Evaluating the Effect of Pharmacological Ascorbate on Radiation Therapy for Pancreatic Cancer Patients — Withdrawn before enrolling
• PARTNER II Trial: Placement of AoRTic TraNscathetER Valves II - S3 Intermediate — Completed
• Mathematical Modeling to Predict the Duration of Thrombocytopenia in Neonates — Status unconfirmed
• The TESLA Trial: Thrombectomy for Emergent Salvage of Large Anterior Circulation Ischemic Stroke — Completed
• PARTNER II Trial: Placement of AoRTic TraNscathetER Valves II - XT Intermediate and High Risk — Completed
• A Study of SY 5609, a Selective CDK7 Inhibitor, in Advanced Solid Tumors — Completed
• Study of Multiple Candidate Agents for the Treatment of COVID-19 in Hospitalized Patients — Completed
• Irrisept Versus Standard of Care in the Prevention of Surgical Site Infections — Stopped early
• Study to Evaluate Eflornithine + Lomustine vs Lomustine in Recurrent Anaplastic Astrocytoma (AA) Patients — Status unconfirmed
• PARTNER II Trial: Placement of AoRTic TraNscathetER Valves II - High Risk and Nested Registry 7 — Completed
• PARTNER II Trial: Placement of AoRTic TraNscathetER Valves II - Nested Registry 3/Valve-in-Valve — Completed
• The PARTNER II Trial: Placement of AoRTic TraNscathetER Valves - PII B — Completed
• A Study to Determine the Immunogenicity and Safety Profile of CSL Limited's Influenza Virus Vaccine Compared to a US Licensed Comparator Influenza Virus Vaccine — Completed
• Calcium and Vitamin D to Optimize Bone Mass in Boys With Risperidone-induced Hyperprolactinemia — Completed
• Elderly Back Pain: Comparing Chiropractic to Medical Care — Completed
• Phase I Dose Escalation Safety Study of RetinoStat in Advanced Age-Related Macular Degeneration (AMD) — Completed
• Efficacy and Tolerability of NM-BL in Patients With Exocrine Pancreatic Insufficiency Due to Cystic Fibrosis — Completed
• Expanding the Role of Pharmacists in Treating Persons With Cardiovascular or Lung Diseases — Completed
• A Collaborative Model to Improve Blood Pressure (BP) Control and Minimize Racial Disparities — Completed
• Study of Obatoclax in Previously Untreated Acute Myeloid Leukemia (AML) — Completed
• Citalopram to Enhance Cognition in HD — Completed
• The Prediction of Extent and Risk Profile of Coronary Atherosclerosis and Their Changes During Lipid-lowering Therapy Based on Non-invasive Techniques — Status unconfirmed
• Atomoxetine and Huntington's Disease — Completed
• Platform Exercise Training — Completed
• Aquatic Power Training — Completed
• Study of ONTAK® to Treat Cutaneous T-Cell Lymphoma (CTCL) — Completed